KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Total Liabilities (2016 - 2025)

Acadia Pharmaceuticals has reported Total Liabilities over the past 16 years, most recently at $336.8 million for Q4 2025.

  • Quarterly results put Total Liabilities at $336.8 million for Q4 2025, down 25.97% from a year ago — trailing twelve months through Dec 2025 was $336.8 million (down 25.97% YoY), and the annual figure for FY2025 was $336.8 million, down 25.97%.
  • Total Liabilities for Q4 2025 was $336.8 million at Acadia Pharmaceuticals, down from $413.5 million in the prior quarter.
  • Over the last five years, Total Liabilities for ACAD hit a ceiling of $455.0 million in Q4 2024 and a floor of $150.7 million in Q3 2021.
  • Median Total Liabilities over the past 5 years was $275.7 million (2023), compared with a mean of $282.2 million.
  • Biggest five-year swings in Total Liabilities: skyrocketed 69.27% in 2023 and later decreased 25.97% in 2025.
  • Acadia Pharmaceuticals' Total Liabilities stood at $159.2 million in 2021, then rose by 17.69% to $187.4 million in 2022, then skyrocketed by 69.27% to $317.2 million in 2023, then skyrocketed by 43.43% to $455.0 million in 2024, then dropped by 25.97% to $336.8 million in 2025.
  • The last three reported values for Total Liabilities were $336.8 million (Q4 2025), $413.5 million (Q3 2025), and $403.2 million (Q2 2025) per Business Quant data.